SightfileU.S. market data from official filings
Companies › PTCT
PTC THERAPEUTICS INC (PTCT)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001070081 · EDGAR filings · Updated 2026-07-16
PTC THERAPEUTICS INC (PTCT) has 349 institutional managers reporting positions valued at $6.52B per the latest 13F reporting period.
Institutional managers
349
Reported 13F value
$6.52B
Insider activity
271 trans.
−$44.7M net selling
Latest updates
- 2026-07-16 — Insider transaction reported (Form 4)
- 2026-07-14 — Notice of proposed sale filed (Form 144)
- 2026-07-13 — Insider transaction reported (Form 4)
- 2026-07-13 — Insider transaction reported (Form 4)
- 2026-07-09 — Notice of proposed sale filed (Form 144)
- 2026-07-09 — Notice of proposed sale filed (Form 144)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, PTC THERAPEUTICS INC has 349 institutional holders.
Insider activity
Insiders reported 271 transactions (0 buys, 181 sells) across 17 reporting insiders, with a net reported value of −$44.7M.
Related companies
COGENT BIOSCIENCES INC (COGT) · APOGEE THERAPEUTICS INC (APGE) · SCHOLAR ROCK HLDG CORP (SRRK) · RHYTHM PHARMACEUTICALS INC COM (RYTM) · AXSOME THERAPEUTICS INC. (AXSM) · MIRUM PHARMACEUTICALS INC (MIRM)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-16.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-16.